Cargando…
ASK1/p38-mediated NLRP3 inflammasome signaling pathway contributes to aberrant retinal angiogenesis in diabetic retinopathy
Diabetic retinopathy (DR) is the leading cause of blindness among the working-age population in several countries. Despite the available treatments, some patients are diagnosed at the late stages of the disease when treatment is more difficult. Hence, it is crucial that novel targets are identified...
Autores principales: | Zou, Wenjun, Luo, Shasha, Zhang, Zhengwei, Cheng, Libo, Huang, Xiaoli, Ding, Nannan, Pan, Ying, Wu, Zhifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797434/ https://www.ncbi.nlm.nih.gov/pubmed/33416127 http://dx.doi.org/10.3892/ijmm.2020.4833 |
Ejemplares similares
-
p38 promoted retinal micro-angiogenesis through up-regulated RUNX1 expression in diabetic retinopathy
por: Zou, Wenjun, et al.
Publicado: (2020) -
Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy
por: Kuo, Charisse Y-J., et al.
Publicado: (2022) -
The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy
por: Chaurasia, Shyam S., et al.
Publicado: (2018) -
The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy
por: Zheng, Xiaoqin, et al.
Publicado: (2023) -
lncRNA HOTAIR promotes ROS generation and NLRP3 inflammasome activation by inhibiting Nrf2 in diabetic retinopathy
por: You, Hui, et al.
Publicado: (2023)